Cellbyte raises $2.75m to fund pharma drug launch platform

Esme Needham | November 27, 2025 | News story | Product launch |  AI, Cellbyte, biotech 

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches.

The complexity of steps such as pricing and reimbursement strategies, regulatory approval and data collection means that novel, life-saving drugs can take over a year to reach the patients who need them. Pharmaceutical companies often spend hundreds of thousands of dollars to access and complete market data in advance of a drug launch. Cellbyte’s AI-native platform, however, is designed to allow drug launch teams to rapidly analyse millions of data points. It aims to determine the most effective launch sequences and market strategies, reducing cost, time and labour.

Cellbyte’s goal is to replace outdated legacy databases, reducing data processes that previously took up to a year to a matter of minutes without loss of quality.

Advertisement

“I’ve seen countless innovations transforming clinical development. Yet in pricing and market access, decisions still too often rely on manual work and anecdotal evidence even though information is so abundant. Now, generative AI is changing that,” said Daniel Moreira, co-CEO and co-founder at Cellbyte.

Felix Steinbrenner, co-CEO and co-founder at Cellbyte, said: “The industry is ready to rethink drug launch workflows and adopt faster, higher quality and cost-effective processes.”

Related Content

Liverpool launches £20m lab for infectious disease drug discovery

A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

Bioptimus has partnered with Cancer Research Horizons, the innovation arm of Cancer Research UK, to …

The Gateway to Local Adoption Series

Latest content